Carcinogenesis Advance Access published online on June 13, 2006
Carcinogenesis, doi:10.1093/carcin/bgl089
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 CR-UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
* To whom correspondence should be addressed. Mismatch repair (MMR) is important for repairing of nucleotide mismatches during DNA replication. Germline mutations in MMR genes are associated with heterditary nonpolyposis colorectal cancer (HNPCC). Ovarian cancer occurs as part of the HNPCC phenotype, and so common variants in MMR genes are candidates for ovarian cancer susceptibility. We performed a large multi-centre case-control study to investigate associations of common variations in MMR genes and ovarian cancer using a single nucleotide polymorphism (SNP) tagging approach. A total of 2570 controls and 1531 cases from three separate studies were genotyped for 44 tagging SNPs (stSNP) in seven MMR genes (MLH1, MLH3, MSH2, MSH3, MSH6, PMS1 and PMS2). Genotype frequencies were marginally different between cases and controls for PMS2 rs7797466 (P2df = 0.046) with a 1.17-fold (95%CI 1.03-1.33) increase in risk for each "a" allele carried (P-trend =0.013). Haplotype analysis of PMS2 also showed significant difference in frequencies between cases and controls (P7df = 0.005), with one haplotype accounting for most of the effect. There was also marginal evidence for a recessive protective effect with common homozygote as the baseline comparator for two SNPs -MSH6 rs3136245 (OR 0.67 95%CI 0.46-0.98) and MSH3 rs6151662 (OR 0.28 95%CI 0.08-0.91) - but the comparisons of genotype frequencies for these variants were not significant (P = 0.10 and 0.054). In conclusion, it is unlikely that common variants in MLH1, MLH3, PMS1, MSH2, MSH3 and MSH6 contribute significantly to ovarian cancer susceptibility. The observed association of PMS2 rs7797466 with ovarian cancer warrants confirmation in an independent study.
Received January 10, 2006
Revised May 9, 2006
Accepted May 9, 2006
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Common variants in mismatch repair genes and risk of invasive ovarian cancer
Honglin Song 1 *,
Susan J. Ramus 2,
Lydia Quaye 2,
Richard A. DiCioccio 3,
Jonathan Tyrer 1,
Emma Lomas 1,
Danielle Shadforth 1,
Estrid Hogdall 4,
Claus Hogdall 4,
Valerie McGuire 5,
Alice S. Whittemore 5,
Douglas F. Easton 6,
Bruce A. J. Ponder 1,
Susanne Kruger Kjaer 4,
Paul D. P. Pharoah 1,
and
Simon A. Gayther 2
2 Translational Research Laboratory, Department of Gynaecological Oncology, University College London, UK
3 Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA
4 Department of Viruses, Hormones, and Cancer, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
5 Department of Health Research and Policy, Stanford University School of Medicine, Stanford, USA
6 CR-UK Genetic Epidemiology Unit, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
Honglin Song, E-mail: honglin{at}srl.cam.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Quaye, D. Dafou, S. J. Ramus, H. Song, A. G. Maharaj, M. Notaridou, E. Hogdall, S. K. Kjaer, L. Christensen, C. Hogdall, et al. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival Hum. Mol. Genet., May 15, 2009; 18(10): 1869 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schildkraut, E. L. Goode, M. A. Clyde, E. S. Iversen, P. G. Moorman, A. Berchuck, J. R. Marks, J. Lissowska, L. Brinton, B. Peplonska, et al. Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer Cancer Res., March 15, 2009; 69(6): 2349 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Goode, B. L. Fridley, R. A. Vierkant, J. M. Cunningham, C. M. Phelan, S. Anderson, D. N. Rider, K. L. White, V. S. Pankratz, H. Song, et al. Candidate Gene Analysis Using Imputed Genotypes: Cell Cycle Single-Nucleotide Polymorphisms and Ovarian Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 935 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Palmieri, M. A. Wilson, E. S. Iversen, M. A. Clyde, B. Calingaert, P. G. Moorman, C. Poole, A. R. Anderson, S. Anderson, H. Anton-Culver, et al. Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3567 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Quaye, S. A. Gayther, S. J. Ramus, R. A. Di Cioccio, V. McGuire, E. Hogdall, C. Hogdall, J. Blaakr, D. F. Easton, B. A.J. Ponder, et al. The Effects of Common Genetic Variants in Oncogenes on Ovarian Cancer Survival Clin. Cancer Res., September 15, 2008; 14(18): 5833 - 5839. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beesley, S. J. Jordan, A. B. Spurdle, H. Song, S. J. Ramus, S. K. Kjaer, E. Hogdall, R. A. DiCioccio, V. McGuire, A. S. Whittemore, et al. Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2557 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Gayther, H. Song, S. J. Ramus, S. K. Kjaer, A. S. Whittemore, L. Quaye, J. Tyrer, D. Shadforth, E. Hogdall, C. Hogdall, et al. Tagging Single Nucleotide Polymorphisms in Cell Cycle Control Genes and Susceptibility to Invasive Epithelial Ovarian Cancer Cancer Res., April 1, 2007; 67(7): 3027 - 3035. [Abstract] [Full Text] [PDF] |
||||



